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ABSTRACT
Objective: Type 1 diabetes mellitus (T1DM) is a widespread metabolic disease, which frequently carries with it a significant impact on human health. 
Oxidative damage and tissue inflammation have been claimed to be a typical pathogenic component for the progression of diabetic complications. 
We aim in this study to explore the relation of urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG) (as a marker of nucleic acid oxidation) to 
microvascular complications in T1DM.
Methods: A case–control study, enrolling 45 T1DM children and an equivalent number of healthy subjects, was performed. Full clinical examination 
and anthropometric measurement were performed to all subjects. Urinary assessment for 8-oxodG and albumin was done in addition to blood 
sampling for lipid profile and glycated Hb (HbA1c) assay. Complete ocular examination for assessment of diabetic retinopathy (DR) was also done.
Results: Levels of urinary 8-oxodG, serum cholesterol, triglycerides, and low-density lipoprotein in cases were significantly higher than non-diabetics; 
these levels were likewise higher in uncontrolled T1DM patients in comparison with well-controlled T1DM subjects. Urinary 8-oxodG and HbA1c 
were significantly higher in diabetic patients with albuminuria and DR compared to patients without complications. Significant positive correlation 
was found between 8-oxodG with HbA1c (r=0.8, p<0.01), diastolic blood pressure (DBP) (r=0.4, p=0.02), and cholesterol (r=0.4, p=0.05).
Conclusion: Urinary 8-oxodG was found to be a reliable marker for assessing oxidative DNA damage in T1DM and can be used in the determination 
of microvascular complications related to diabetes.
Keywords: Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine, Type1 diabetes, DNA oxidation, Microvascular complications.
INTRODUCTION
Type 1 diabetes mellitus (T1DM) is considered one of the most frequent 
endocrine diseases in children. These young children confront a long 
period of hyperglycemia in their prepubertal years with the danger 
of early occurrence of micro- and macrovascular complications [1]. 
In spite of the fact that complications from T1DM are rare among 
children, endothelial dysfunction which is an early pointer of vascular 
insufficiency may happen [2,3]. Around 80% of patients with diabetes 
die from thrombotic events; 75% of these passings are because of 
cardiovascular complications and the rest due to cerebrovascular and 
peripheral vascular diseases [4].
The role of oxidative damage in the mechanisms of diabetic hazards was 
the focus of interest in the previous years. Expanded levels of markers 
of oxidative stress were obvious in the diabetic state, and recent 
reviews showed that oxidative stress plays a crucial role in mediating 
the pathophysiology of these complications [5,6]. DNA oxidation 
marker (8-oxodG) is a novel biomarker that could be used as a marker 
of oxidative stress in diabetes. Urinary levels of this biomarker can be 
evaluated in urine as a noninvasive technique; this makes it an easier 
way for hazard detection and management plan [7,8].
The most frequently measured urinary marker of oxidative stress, and 
for diabetic complications in adult (Type 2 diabetes) is 8-OxodG [9], 
however, no enough studies focusing on this marker concentration in 
diabetic children and adolescents (Type 1). In this study, we aimed to 
assess the urinary 8-OHdG diagnostic ability in the identification of 
microvascular complications in T1DM.
METHODS
This was a case–control study. 45 diabetic children and adolescents 
with T1DM attending Pediatric Diabetic Clinic of Children Hospital, Ain 
Shams University, and 45 matched healthy subjects aged 6-16 years 
were included. T1DM patients were further subdivided according to 
HbA1c into Group I with HbA1C of 8% or less (well-controlled T1DM) 
and Group II with HbA1c >8% (poorly controlled T1DM).
Subjects were excluded for any of the following reasons: Presence of 
acute infection at the time of testing; medications or hormones (other 
than insulin); the presence of known renal disease; or systemic disease 
and other chronic or inflammatory disease. After taking a written 
informed consent from the parents of children enrolled in the study, 
each child was subjected to a complete physical examination, a detailed 
medical history, and anthropometric measurements. Their weight was 
measured using a digital scale (Seca, Hamburg, Germany) to the nearest 
0.1 kg with the children dressed in minimal clothes and without shoes. 
Their height was measured using a Seca 225 stadiometer to the nearest 
0.1 cm [10]. The body mass index (BMI) was calculated as the weight 
(kg) divided by the height (m) squared. Weight, height, and BMI standard 
deviation score (SDS) were assessed using the new WHO reference [11]. 
Blood pressure (BP) was measured by a sphygmomanometer (Accoson, 
London, UK) as the mean of two measurements. BP (SDS) was 
determined using the German references [12].
About 3 ml of venous blood samples after an 8 hrs fasting were 
collected from each subject in sterile plain vacutainer tubes. Blood on 
the plain tubes was allowed to clot for 30 minutes, and then centrifuged 
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at 3000× g for 10 minutes then the serum was separated and frozen at 
−20°C until the time of assay to avoid erroneous results from repeated 
freeze/thaw cycles. Total cholesterol and triglyceride and high-density 
lipoprotein (HDL) were determined using colorimetric techniques 
on Synchron Cx7 (Beckman Instruments Inc., California, USA). Low-
density lipoprotein (LDL) cholesterol was measured by Friedwald et al. 
formula [13]. Fasting blood glucose level was performed on automated 
clinical chemistry analyzer (OLYMPUS AU400).
Early morning urine samples were collected, centrifuged at 
3000× g for 10 minutes as any precipitation may affect analysis of 
albumin in urine, and then the supernatant was stored at −20°C till 
albumin and creatinine measurement, as a variations in urine flow 
rate are corrected by expressing albumin as a ratio to creatinine (mg 
albumin/gram creatinine) where values <30 is normal, 30-300 there is 
microalbuminuria, >300 show macroalbuminuria.
Albumin in urine was performed on a spectrophotometer (BioSystems 
BTS-302) using BioSystems kit (BioSystem S.A. Costa Brava, 
30.08030 Barcelona [Spain]). Creatinine in urine was measured on a 
spectrophotometer (BioSystems BTS-302) using BIODIAGNOSTIC kit 
(colorimetric Kinetic Method) [14].
Human 8-oxo 7.8 dihydro-2deoxyguanisine was assayed in urine using 
human 8-oxo 7.8 dihydro-2deoxyguanisine ELISA kit, Kono Biotech Co., 
Ltd. The result was expressed as a ratio to urinary creatinine to correct 
the variation in urinary flow.
Diabetic retinopathy (DR) was diagnosed by doing complete ocular 
examination including visual field testing, slit-lamp biomicroscopy, and 
indirect ophthalmoscopy. Fundus examination was performed through 
dilated pupils using 90-diopter Volk lens and biomicroscope. The 
presence and grading of DR were based on the International clinical DR 
and macular edema disease severity scale [15].
Statistical analyses
Data entry was carried on excel sheet, and statistical analysis was 
performed using SPSS software program version 18.0 (IBM, Chicago, IL, 
USA). Data were analyzed, characteristics of the sample were presented; 
mean and standard deviation were estimated as regarding age, BMI 
(SDS), systolic and diastolic BP (SDS), the level of HbA1C, cholesterol, 
triglyceride, and level of 8-oxodG. On the other hand, numbers and 
percentages were calculated as regard sex distribution and presence 
of albuminuria. Chi-square was done for comparison of qualitative 
data that presented by numbers and percentages, t-test was done for 
comparison between two means, and Pearson Correlation was done 
for relations between two quantitative variables. Linear regression 
analysis was performed to predict risk factors significantly associated 
with increased level of 8-oxodG. p value was considered statistically 
significant when p<0.05 and considered statistically highly significant 
when its value was <0.01.
RESULTS
A total of 90 children were recruited in our study: 44 Type 1 diabetic 
children and an equal number of healthy children as controls. 
Demographic and laboratory data of studied cases are shown in Table 1.
There was no difference between cases and controls regarding age or 
gender. Mean levels of urinary 8-oxodG, serum cholesterol, triglycerides 
(TG), LDL and as expected, HbA1c, showed a significant increase in 
T1DM children compared to control. Meanwhile, the mean value of 
anthropometric measurements was indifferent between the two groups 
(Table 1). 26% of patients had albuminuria with a mean duration of 
illness of 8.2 years.
Uncontrolled T1DM patients had higher diastolic BP (DBP) SDS, urinary 
8-oxodG, serum cholesterol, TG and LDL levels compared to the well-
controlled diabetic group. Albuminuria, measured in mg/gm creatinine, 
was also higher in poorly controlled patients (Table 2).
Table 3 shows that diabetic children with albuminuria had higher levels 
of urinary 8-oxodG, HbA1c and higher values of DBP (SDS) compared to 
non-albuminuric patients, while no difference in levels of lipid profile 
or anthropometric measurements was found regarding the presence 
of albuminuria. Urinary 8-oxodG levels were also found to be higher in 
cases diagnosed with retinopathy compared to other cases (Fig. 1).
Correlation analysis between urinary 8-oxodG and lipid profile, BMI, 
BP (SDS), glycated Hb, duration of illness in diabetic children revealed 
positive association between 8-oxodG with DBP (SDS) (r=0.4, p=0.02), 
glycated Hb (r=0.8, p<0.001) (Fig. 2), and serum cholesterol (r=0.4 
p=0.05). There was no significant correlation between 8-oxodG and 
other parameters. Significant positive correlations were also found 
between DBP (SDS) and duration of diabetes (r=0.4, p=0.05) and HbA1c 
(r=0.5, p=0.02).
Linear regression analysis was applied to recognize factors influencing 
8-oxodG serum levels. HbA1c was found to be the most effective factor 
predicting the level of urinary 8-oxodG followed by DBP and serum 
cholesterol (Table 4).
Table 2: Clinical and laboratory characteristics of Type 1 
diabetic patients as regard diabetic control





Weight −0.6±0.7 0.4±1.2 0.02
Height −0.8±1.3 −0.4±1.5 0.5
BMI 0±0.6 0.8±1.2 0.5
SDS 0.7±0.2 0.9±0.4 0.3
DBS 0.6±0.5 1.1±0.6 0.03*
TG (mg/dl) 144.5±20 163±15.5 0.00**
Cholesterol (mg/dl) 211.6±34.2 246.4±30.4 0.00**
HDL (mg/dl) 24.6±5 29.1±7 0.1







*p≤0.05 is significant, **p≤0.01 is highly significant,  DBP: Diastolic blood 
pressure, BMI: Body mass index, SDS: Standard deviation score, LDL: 
Low-density lipoprotein, HDL: High-density lipoprotein, *p≤0.05 is significant, 
**p≤0.01 is highly significant, SD: Standard deviation, TG: Triglycerides
Table 1: Baseline characteristics and biochemical parameters of 
the studied population
Variables Mean±SD p value
Cases n=45 Control n=45
Age (years) 10.1±3.4 10.4±3.4 0.7
Sex n (%)
Male 20 (44.4) 21 (46.6) 0.2
Female 25 (55.6) 24 (53.4)
Weight 0.05±1.1 −0.4±1 0.1
Height −0.6±1.4 −.05±1.3 0.8
BMI 0.6±1.1 1.1±0.6 0.4
DBP 1.0±0.6 0.4±0.6 <0.01**
SDS 0.9±0.8 0.1±0.8 <0.01**
Glycated Hb 8.9±2.5 5.3±0.4 <0.01**
TG (mg/dl) 156.8±18.9 72.5±7.1 <0.01**
Cholesterol (mg/dl) 234.8±35.3 139.3±16.5 <0.01**
HDL (mg/dl) 27.6±6.8 52.3±4.4 <0.01**




**p≤0.01 is highly significant, DBP: Diastolic blood pressure, BMI: Body 
mass index, SDS: Standard deviation score, LDL: Low-density lipoprotein, 
HDL: High-density lipoprotein, TG: Triglycerides
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DISCUSSION
With the expansion of the incidence rate of diabetes, more research 
is expected to be done to study its pathogenic mechanism and locate 
the applicable management. Despite the complexity of mechanisms 
underlying diabetes and its complications, oxidative stress gives a new 
sight [16]. Oxidative stress is defined as a disturbance of the balance 
between production and detoxification of reactive oxygen resulting 
in failure to repair the subsequent damage. This disturbance can lead 
to harmful impacts through the formation of reactive oxygen species 
(ROS) leading to disruption of cellular components including nucleic 
acids, lipids, and proteins [17,18].
Urinary 8-oxodG level was found to be higher in diabetic children 
in comparison to control in our study. Similar results were found in 
Chinese study performed on Type 2 diabetic patients, where urinary 
concentrations of 8-oxodG were obviously higher compared to 
healthy controls [19]. Levels of urinary 8-oxodG were also positively 
associated with HbA1c as these levels were significantly higher in 
uncontrolled T1DM patients (HbA1c ≥8) compared to controlled 
patients (HbA1c <8) this was confirmed when a linear regression 
was applied to predict factors influencing urinary levels of 8-oxodG 
and finding that HbA1c is the most affecting factor. This comes in 
agreement with results of the previous studies showing that poor 
glycemic control is one of the most important factors that lead 
to oxidative DNA damage [20,21]. Similarly, Dong et al. showed a 
significant correlation between urinary 8-oxodG and glycated Hb in 
the T1DM patients (r=0.53) [19]. These findings can be explained 
by increased formation of ROS that can lead to the development 
of multiple DNA lesions; (8-oxodG) is one of the most broadly 
examined lesions. The repair products of these lesions are excreted 
in urine [22]. 8-oxodG was tested in urine rather than in blood, which 
was explained by the following three reasons. First, blood levels of 
8-oxodG were mostly determined by the kidney function, and when 
different cases were compared, they were unlikely to give accurate 
data about oxidative anxiety. Furthermore, urine contained a larger 
amount of oxidized guanosine than blood, hence giving a higher 
accuracy [23]. Third, the urine sample was obtained noninvasively 
and more easily than blood.
Diabetic children also have elevated lipid profile (TG, LDL, and 
cholesterol) and BP (SBP, and DBP) compared to controls. These 
results coincide with the previous data which proved that BP and 
lipid profile are elevated in diabetic children with the presence of 
positive correlation between DBP with diabetes duration and HbA1c 
levels [24-26]. The possible relationship between these factors and 
urinary 8-oxodG had been discussed in only a few studies. Current 
study findings showed a positive correlation between urinary 8-oxodG 
and both DBP (SDS) and serum cholesterol. This matches Hinokio et al. 
findings of increased urinary 8-oxodG levels in hypertensive diabetic 
patients in comparison to normotensive ones [27]. In the contrary, 
no significant association was found between urinary 8-oxodG and 
hypertension in other studies [21,28].
In addition, we found higher urinary 8-oxodG levels in diabetic patients 
with microalbuminuria in comparison with non-albuminuric patients. 
Similar results were observed in the previous studies with two-fold 
higher levels of 8-oxodG in diabetic patients with microalbuminuria 
compared to T1DM patients with no albumin in urine [28,29]. This 
Table 3: Clinical and laboratory characteristics of Type 1 
diabetic patients as regard presence of albuminuria





SDS 0.7±0.3 1.1±0.7 0.3
DBP 0.5±0.2 1.1±0.6 0.03*
TG (mg/dl) 158±21.1 153.4±11.4 0.6
Cholesterol (mg/dl) 236.6±39.4 229.7±21.5 0.6
HDL (mg/dl) 28.8±7.4 24.5±4.1 0.1
LDL (mg/dl) 176.3±28.6 174.5±15.5 0.8
8-oxodG (ng/mg creatinine) 95.0±6.4 411.5±349.5 0.002**
HbA1C (%) 8.3 10.4 0.001**
*p≤0.05 is significant, **p≤0.01 is highly significant, DBP: Diastolic 
blood pressure, BMI: Body mass index, SDS: Standard deviation score, 
LDL: Low-density lipoprotein, HDL: High-density lipoprotein, TG: Triglycerides
Fig. 1: 8-oxodG levels in diabetic cases with and without 
retinopathy
Fig. 2: Correlation between urinary 8-oxodG and diastolic blood 
pressure (standard deviation score)
Table 4: Linear regression analysis shows predictive factors for 









Glycated Hb 6.7 2.1 0.7 5.3 0.001**
TG 0.7 0.4 0.2 1.2 0.1
Cholesterol 0.3 0.2 0.1 1.9 0.05*
LDL 1.3 0.8 0.3 1.1 0.09
HDL 1.7 0.9 0.8 1.0 0.1
BMI (SDS) 5.1 3.1 0.4 1.5 0.08
SBP (SDS) 3.8 2.1 0.8 1.7 0.07
DBP (SDS) 8.6 3.7 0.9 2.5 0.02*
Dependent Variable: urinary 8-oxodG. Entered factors are: age, Glycated Hb, 
LDL, HDL, Cholesterol, TG, Body mass index (SDS), systolic blood pressure 
(SDS), diastolic blood pressure (SDS). *p≤0.05 is significant, **p≤0.01 is highly 
significant
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can be explained by the positive association between tubulointerstitial 
and glomerular injury caused by diabetic state and urinary 8-oxodG 
excretion [30].
Diabetic patients in this study underwent full ocular examination, and 
those who were diagnosed with DR had significantly elevated urinary 
8-oxodG concentrations compared to those with no retinopathy. This 
comes in agreement with results of the previous works that assessed 
the relationship between the degree of retinal affection in diabetic 
patients and their urinary levels of 8-oxodG [31].
Again, we can refer the previous diabetic microvascular complications 
to the oxidative damage that happens when the ROS level overpowers 
defensive mechanisms, leading to a cellular imbalance between 
pro- and antioxidant factors [32]. Elevated levels of oxidation 
markers such as 8-oxodG most likely prompt to strand breaks and 
oxidative base changes; and multiple signaling pathways that may 
likewise add to the unfavorable impacts of glucotoxicity on cellular 
functions [33,34].
DNA oxidation can lead to microvascular complications of diabetes 
through different mechanisms; the most important of them is the 
induction of cell senescence via either telomeric or non-telomeric DNA 
damage [35]. This senescence leads to vasculopathy and atherosclerosis 
and finally the clinical signs of the vascular complications observed in 
diabetes [36].
In summary, this study demonstrated significantly higher levels of 
oxidative DNA damage in patients with Type 1 diabetes compared 
with healthy control subjects, and that Type 1 diabetes patients with 
complications have increased urinary 8-oxodG excretion compared 
with those without complications. We propose the role for 8-oxodG as a 
molecular mechanism contributing to the microvascular complications 
of Type 1 diabetes. Further studies ought to be initiated to assess the 
potential clinical applications of 8-oxodG as a biomarker in diabetes 
that could be used for risk stratification, progressive course, selection of 
appropriate therapeutic intervention, and the monitoring of response 
to therapy.
REFERENCES
1. Soltesz G, Patterson C, Dahlquist G. Diabetes in the Young: A Global 
Perspective IDF Diabetes Atlas. 4th ed. Pecs, Hungary: Department of 
Pediatrics; 2009. p. 1-36.
2. Scaramuzza AE, Redaelli F, Giani E, Macedoni M, Giudici V, 
Gazzarri A, et al. Adolescents and young adults with Type 1 diabetes 
display a high prevalence of endothelial dysfunction. Acta Paediatr 
2015;104(2):192-7.
3. Prabhakar PK. Pathophysiology of secondary complications of diabetes 
mellitus. Asian J Pharm Clin Res 2016;9(1):32-6.
4. Madan R, Gupt B, Saluja S, Kansra UC, Tripathi BK, Guliani BP. 
Coagulation profile in diabetes and its association with diabetic 
microvascular complications. J Assoc Physicians India 2010;58:481-4.
5. Calcutt NA, Cooper ME, Kern TS, Schmidt AM. Therapies for 
hyperglycaemia-induced diabetic complications: From animal models 
to clinical trials. Nat Rev Drug Discov 2009;8(5):417-29.
6. Altincik A, Tuglu B, Demir K, Çatli G, Abaci A, Böber E. Relationship 
between oxidative stress and blood glucose fluctuations evaluated with 
daily glucose monitoring in children with Type 1 diabetes mellitus. 
J Pediatr Endocrinol Metab 2016;29(4):435-9.
7. Broedbaek K, Siersma V, Henriksen T, Weimann A, Petersen M, 
Andersen JT, et al. Urinary markers of nucleic acid oxidation and 
cancer in Type 2 diabetes. Redox Biol 2015;4:34-9.
8. Rochette L, Zeller M, Cottin Y, Vergely C. Diabetes, oxidative stress and 
therapeutic strategies. Biochim Biophys Acta 2014;1840(9):2709-29.
9. Tatsch E, Bochi GV, Piva SJ, De Carvalho JA, Kober H, Torbitz VD, 
et al. Association between DNA strand breakage and oxidative, 
inflammatory and endothelial biomarkers in Type 2 diabetes. Mutat Res 
2012;732(1-2):16-20.
10. Lohman TG, Roche AF, Martorell R. Human variation in anthropometric 
dimensions. In: Anthropometric Standardization Reference Manual. 
Champaign, IL: Human Kinetics Publishers; 1988. p. 86-107.
11. Group WMGRS. WHO child growth standards: Length/height-
forage, weight-for-age, weight-for-length, weight-for-height and 
body mass index-for-age: Methods and development. In: WHO Press, 
editors. WHO Child Growth Standards. Geneva, Switzerland: World 
Health Organization; 2006. p. 312. Available from: http://www.who.
int/childgrowth/standards/Technical_report.pdf. [Last accessed on 
2011 Aug 11].
12. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F; German Working 
Group on Pediatric Hypertension. Distribution of 24-h ambulatory 
blood pressure in children: Normalized reference values and role of 
body dimensions. J Hypertens 2002;20(10):1995-2007.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the 
concentration of low-density lipoprotein cholesterol in plasma, 
without use of the preparative ultracentrifuge. Clin Chem 
1972;18(6):499-502.
14. Pagel J. Biographisches Lexikon hervorragender Ärzte des Neunzehnten 
Jahrhunderts. Berlin: Urban & Schwarzenberg; 2012. p. 814. Available 
from: https://archive.org/details/biographischesl01pagegoog. [Last 
retrieved on 2012 Oct 19].
15. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, 
et al. Proposed international clinical diabetic retinopathy and 
diabetic macular edema disease severity scales. Ophthalmology 
2003;110(9):1677-82.
16. Krauss RM. Lipids and lipoproteins in patients with Type 2 diabetes. 
Diabetes Care 2004;27(6):1496-504.
17. Broedbaek K, Weimann A, Stovgaard ES, Poulsen HE. Urinary 8-oxo-
7,8-dihydro-2’-deoxyguanosine as a biomarker in Type 2 diabetes. Free 
Radic Biol Med 2011;51(8):1473-9.
18. El-Gindi HD, Hassanin AI, Mostafa NO, El-Kassas GM, El Wakeel MA, 
El-Batal WH, et al. Oxidative DNA damage in β-thalassemic children. 
Med Res J 2015;14(2):41-6.
19. Dong QY, Cui Y, Chen L, Song J, Sun L. Urinary 
8-hydroxydeoxyguanosine levels in diabetic retinopathy patients. Eur 
J Ophthalmol 2008;18(1):94-8.
20. Al-Aubaidy HA, Jelinek HF. Oxidative DNA damage and obesity in 
Type 2 diabetes mellitus. Eur J Endocrinol 2011;164(6):899-904.
21. Xu GW, Yao QH, Weng QF, Su BL, Zhang X, Xiong JH. Study of 
urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA 
damage in diabetic nephropathy patients. J Pharm Biomed Anal 
2004;36(1):101-4.
22. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: A marker of 
oxidative stress to DNA and a risk factor for cancer, atherosclerosis and 
diabetics. Clin Chim Acta 2004;339(1-2):1-9.
23. Poulsen HE, Nadal LL, Broedbaek K, Nielsen PE, Weimann A. 
Detection and interpretation of 8-oxodG and 8-oxoGua in 
urine, plasma and cerebrospinal fluid. Biochim Biophys Acta 
2014;1840(2):801-8.
24. El Wakeel MA, El-Kassas GM, Amer AF, Elbatal WH, Sabry RN, 
EL-Ghaffar Mohammed NA. E-selectin and vascular complications in 
children with Type 1 diabetes mellitus. Med Res J 2014;13(1):27-32.
25. Soubra L, Nureddin H, Omar AG, Saleh M. Factors associated with 
hypertension prevalence and control among lebanese Type 2 diabetic 
patients. Int J Pharm Pharm Sci 2016;8(10):153-9.
26. Nayak B, Bhaktha G. Inconsistent lipid profiles exhibited among the 
diabetic Asian Indians of India and trinidad - A comparative study. Int J 
Pharm Pharm Sci 2016;8(12):60-3.
27. Hinokio Y, Suzuki S, Hirai M, Suzuki C, Suzuki M, Toyota T. 
Urinary excretion of 8-oxo-7, 8-dihydro-2’-deoxyguanosine as a 
predictor of the development of diabetic nephropathy. Diabetologia 
2002;45(6):877-82.
28. Nishikawa T, Sasahara T, Kiritoshi S, Sonoda K, Senokuchi T, 
Matsuo T, et al. Evaluation of urinary 8-hydroxydeoxy-guanosine as 
a novel biomarker of macrovascular complications in Type 2 diabetes. 
Diabetes Care 2003;26(5):1507-12.
29. Shimoike T, Inoguchi T, Umeda F, Nawata H, Kawano K, Ochi H. The 
meaning of serum levels of advanced glycosylation end products in 
diabetic nephropathy. Metabolism 2000;49(8):1030-5.
30. Kanauchi M, Nishioka H, Hashimoto T. Oxidative DNA damage 
and tubulointerstitial injury in diabetic nephropathy. Nephron 
2002;91(2):327-9.
31. Tatsch E, De Carvalho JA, Hausen BS, Bollick YS, Torbitz VD, 
Duarte T, et al. Oxidative DNA damage is associated with inflammatory 
response, insulin resistance and microvascular complications in Type 2 
diabetes. Mutat Res 2015;782:17-22.
32. Liu X, Gan W, Zou Y, Yang B, Su Z, Deng J, et al. Elevated 
levels of urinary markers of oxidative DNA and RNA damage 
in Type 2 diabetes with complications. Oxid Med Cell Longev 
2016;2016:4323198.
322
Asian J Pharm Clin Res, Vol 10, Issue 10, 2017, 318-322
 El Wakeel  et al. 
33. Erusalimsky JD. Vascular endothelial senescence: From mechanisms to 
pathophysiology. J Appl Physiol 2009;106(1):326-32.
34. Nithya K, Isabel W, Angeline T, Priscilla AS, Asirvatham AJ. 
Assessment of DNA strand breaks and total antioxidant status in 
patients with Type 2 diabetes with and without complications: A case-
control study. Asian J Pharm Clin Res 2017;10(4):430-4.
35. Cooke MS, Olinski R, Loft S; European Standards Committee 
on Urinary (DNA) Lesion Analysis. Measurement and meaning 
of oxidatively modified DNA lesions in urine. Cancer Epidemiol 
Biomarkers Prev 2008;17(1):3-14.
36. Brodsky SV, Gealekman O, Chen J, Zhang F, Togashi N, Crabtree M, 
et al. Prevention and reversal of premature endothelial cell senescence 
and vasculopathy in obesity-induced diabetes by ebselen. Circ Res 
2004;94(3):377-84.
